Population Health Sciences

You are here

Publications

Found 191 results

Filters: First Letter Of Last Name is H [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

R

Zang C, Hou Y, Schenck E, Xu Z, Zhang Y, Xu J, Bian J, Morozyuk D, Khullar D, Nordvig A et al.. 2023. Risk Factors and Predictive Modeling for Post-Acute Sequelae of SARS-CoV-2 Infection: Findings from EHR Cohorts of the RECOVER Initiative.. Res Sq.

DesRoches CM, Barrett KA, Harvey BE, Kogan R, Reschovsky JD, Landon BE, Casalino LP, Shortell SM, Rich EC. 2015. The Results Are Only as Good as the Sample: Assessing Three National Physician Sampling Frames.. J Gen Intern Med. 30 Suppl 3:S595-601.

Knupp KG, Coryell J, Nickels KC, Ryan N, Leister E, Loddenkemper T, Grinspan Z, Hartman AL, Kossoff EH, Gaillard WD et al.. 2016. Response to treatment in a prospective national infantile spasms cohort.. Ann Neurol. 79(3):475-84.

Knupp KG, Coryell J, Nickels KC, Ryan N, Leister E, Loddenkemper T, Grinspan Z, Hartman AL, Kossoff EH, Gaillard WD et al.. 2016. Response to treatment in a prospective national infantile spasms cohort.. Ann Neurol. 79(3):475-84.

Knupp KG, Leister E, Coryell J, Nickels KC, Ryan N, Juarez-Colunga E, Gaillard WD, Mytinger JR, Berg AT, Millichap J et al.. 2016. Response to second treatment after initial failed treatment in a multicenter prospective infantile spasms cohort.. Epilepsia. 57(11):1834-1842.

Knupp KG, Leister E, Coryell J, Nickels KC, Ryan N, Juarez-Colunga E, Gaillard WD, Mytinger JR, Berg AT, Millichap J et al.. 2016. Response to second treatment after initial failed treatment in a multicenter prospective infantile spasms cohort.. Epilepsia. 57(11):1834-1842.

Rosenkranz KM, Ballman K, McCall L, Kubicky CDai, Cuttino L, Le-Petross H, Hunt K, Giuliano A, Van Zee K, Haffty B et al.. 2019. Reply to "Can Patients with Multiple Breast Cancers in the Same Breast Avoid Mastectomy by Having Multiple Lumpectomies to Achieve Equivalent Rates of Local Breast Cancer Recurrence? Response to the Preliminary Alliance 11102 Trial Report". Ann Surg Oncol. 26(2):702.

Rosenkranz KM, Ballman K, McCall L, Kubicky CDai, Cuttino L, Le-Petross H, Hunt K, Giuliano A, Van Zee K, Haffty B et al.. 2019. Reply to "Can Patients with Multiple Breast Cancers in the Same Breast Avoid Mastectomy by Having Multiple Lumpectomies to Achieve Equivalent Rates of Local Breast Cancer Recurrence? Response to the Preliminary Alliance 11102 Trial Report". Ann Surg Oncol. 26(2):702.

Bond AM, Volpp KG, Emanuel EJ, Caldarella K, Hodlofski A, Sacks L, Patel P, Sokol K, Vittore S, Calgano D et al.. 2019. Real-time Feedback in Pay-for-Performance: Does More Information Lead to Improvement? J Gen Intern Med.

P

Xie Y, Valdimarsdóttir UA, Wang C, Zhong XR, Gou Q, Zheng H, Deng L, He P, Hu K, Fall K et al.. 2020. Public health insurance and cancer-specific mortality risk among patients with breast cancer: A prospective cohort study in China.. Int J Cancer.

Xie Y, Valdimarsdóttir UA, Wang C, Zhong XR, Gou Q, Zheng H, Deng L, He P, Hu K, Fall K et al.. 2020. Public health insurance and cancer-specific mortality risk among patients with breast cancer: A prospective cohort study in China.. Int J Cancer.

Law A, Hays J, Shonkoff SB, Finkel ML. 2014. Public Health England's draft report on shale gas extraction.. BMJ. 348:g2728.

Frey MK, Kahn RM, Chapman-Davis E, Tubito F, Pires M, Christos P, Anderson S, Mukherjee S, Jordan B, Blank SV et al.. 2020. Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling.. J Clin Oncol. 38(13):1389-1397.

Hood JE, Behrends CN, Irwin A, Schackman BR, Chan D, Hartfield K, Hess J, Banta-Green C, Whiteside L, Finegood B et al.. 2019. The projected costs and benefits of a supervised injection facility in Seattle, WA, USA.. Int J Drug Policy. 67:9-18.

Hood JE, Behrends CN, Irwin A, Schackman BR, Chan D, Hartfield K, Hess J, Banta-Green C, Whiteside L, Finegood B et al.. 2019. The projected costs and benefits of a supervised injection facility in Seattle, WA, USA.. Int J Drug Policy. 67:9-18.

Hood JE, Behrends CN, Irwin A, Schackman BR, Chan D, Hartfield K, Hess J, Banta-Green C, Whiteside L, Finegood B et al.. 2019. The projected costs and benefits of a supervised injection facility in Seattle, WA, USA.. Int J Drug Policy. 67:9-18.

Wen H, Hockenberry JM, Jeng PJ, Bao Y. 2019. Prescription Drug Monitoring Program Mandates: Impact On Opioid Prescribing And Related Hospital Use.. Health Aff (Millwood). 38(9):1550-1556.

McDonough TL, Paolicchi JM, Heier LA, Das N, Engel M, Perlman JM, Grinspan ZM. 2017. Prediction of Future Epilepsy in Neonates With Hypoxic-Ischemic Encephalopathy Who Received Selective Head Cooling.. J Child Neurol. 32(7):630-637.

Grinspan ZM, Shapiro JS, Abramson EL, Hooker G, Kaushal R, Kern LM. 2015. Predicting frequent ED use by people with epilepsy with health information exchange data.. Neurology. 85(12):1031-8.

Hildick-Smith GJ, Pesko MF, Shearer L, Hughes JM, Chang J, Loughlin GM, Ipp LS. 2015. A Practitioner's Guide to Electronic Cigarettes in the Adolescent Population.. J Adolesc Health. 57(6):574-9.

Hildick-Smith GJ, Pesko MF, Shearer L, Hughes JM, Chang J, Loughlin GM, Ipp LS. 2015. A Practitioner's Guide to Electronic Cigarettes in the Adolescent Population.. J Adolesc Health. 57(6):574-9.

Richardson JE, Kern LM, Silver M, Jung H-Y, Kaushal R. 2016. Physician Satisfaction in Practices That Transformed Into Patient-Centered Medical Homes: A Statewide Study in New York.. Am J Med Qual. 31(4):331-6.

Jung H-Y, Unruh MAaron, Vest JR, Casalino LP, Kern LM, Grinspan ZM, Bao Y, Kaushal R. 2017. Physician Participation in Meaningful Use and Quality of Care for Medicare Fee-for-Service Enrollees.. J Am Geriatr Soc. 65(3):608-613.

Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, Vaishampayan U, Armstrong AJ, Stein M, Pinski J et al.. 2019. A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.. Clin Cancer Res. 25(1):43-51.

Martin P, Ruan J, Furman R, Rutherford S, Allan J, Chen Z, Huang X, DiLiberto M, Chen-Kiang S, Leonard JP. 2019. A phase I trial of palbociclib plus bortezomib in previously treated mantle cell lymphoma.. Leuk Lymphoma. :1-5.